Article 5. Limitation of Commercial Use <strong>to</strong> Medical and ScientificPurposes1. Each Party shall limit <strong>the</strong> trade in, and import, export, manufacture, distribution,possession and use of substances in Schedule I as provided in article 7 <strong>to</strong> medical andscientific purposes.2. Each Party shall, except as provided in article 4, limit by such measures as it considersappropriate <strong>the</strong> manufacture, export, import, distribution and s<strong>to</strong>cks of, and trade in,and use and possession of, substances in Schedules II, III and IV <strong>to</strong> medical and scientificpurposes.3. It is desirable that Parties do not permit <strong>the</strong> possession of substances in Schedules II, IIand IV except <strong>un</strong>der legal authority.5.1.4. Option 2 – changes <strong>to</strong> Article 5Article 5(2) of <strong>the</strong> 1971 Convention requires Parties <strong>to</strong> limit manufacture, export, import,distribution, s<strong>to</strong>cks of, trade in, and use and possession of Schedule II, III and IVsubstances <strong>to</strong> medical and scientific purposes. Therefore, Article 5(2) would need <strong>to</strong> beremoved from <strong>the</strong> Convention <strong>un</strong>der Option 2 <strong>to</strong> allow Parties <strong>to</strong> permit non-medicaland non-scientific markets in <strong>the</strong>se substances.For <strong>the</strong> same reasons as discussed above in relation <strong>to</strong> Option 1, Article 5(3) should alsobe deleted.In addition, Article 5(1) should be deleted <strong>to</strong> remove <strong>the</strong> limitation of use of Schedule Isubstances as provided in Article 7 (<strong>to</strong> scientific and very limited medical purposes byduly authorised persons in Government controlled or approved medicalestablishments.). This is discussed fur<strong>the</strong>r in section 7.2.It should be noted that <strong>un</strong>der Option 2, Parties would still be required <strong>to</strong> apply <strong>the</strong>control measures set out in Articles 8, 12 and 13 of <strong>the</strong> 1971 Convention <strong>to</strong> manufacture,distribution, import and export of, and trade in, Schedule II, III and IV substances,whe<strong>the</strong>r for medical/scientific or non-medical/non-scientific purposes.Article 8 requires Parties <strong>to</strong> licence <strong>the</strong> manufacture of, trade (including internationaltrade) in, and distribution of Schedule II, III and IV substances, <strong>to</strong> control all authorisedpersons involved in <strong>the</strong>se activities, and <strong>to</strong> licence <strong>the</strong> establishments and premises inwhich <strong>the</strong>se activities take place. (Article 8 is discussed fur<strong>the</strong>r in section 5.3.)Similar <strong>to</strong> Article 31(4) of <strong>the</strong> 1961 Convention, Article 12 of <strong>the</strong> 1971 Conventionrequires Parties permitting import or export of Schedule I or II substances <strong>to</strong> requireseparate import and export authorisations for each import and export, and <strong>to</strong> require animport certificate from <strong>the</strong> importing co<strong>un</strong>try before issuing an export authorisation.Article 13 allows a Party <strong>to</strong> notify o<strong>the</strong>r Parties that it prohibits import of specified141
substances in<strong>to</strong> its co<strong>un</strong>try or one or more of its regions, in which case Parties must takemeasures <strong>to</strong> ensure that it does not export <strong>the</strong> specified substances <strong>to</strong> <strong>the</strong> co<strong>un</strong>try orregions.5.1.5. Option 2 – amendment of Article 5Article 5 should be deleted.Article 5. Limitation of Use <strong>to</strong> Medical and Scientific Purposes1. Each Party shall limit <strong>the</strong> use of substances in Schedule I as provided in article 7.2. Each Party shall, except as provided in Article 4, limit by such measures as itconsiders appropriate <strong>the</strong> manufacture, export, import, distribution and s<strong>to</strong>cks of, tradein, and use and possession of, substances in Schedules II, III and IV <strong>to</strong> medical andscientific purposes.3. It is desirable that Parties do not permit <strong>the</strong> possession of substances in Schedules II, IIand IV except <strong>un</strong>der legal authority.5.2. Article 7 – prohibition of use of Schedule 1 substancesArticle 7 [Existing text]Special Provisions Regarding Substances in Schedule 1In respect of substances in Schedule 1, <strong>the</strong> Parties shall:a) Prohibit all use except for scientific and very limited medical purposes by dulyauthorised persons, in medical or scientific establishments which are directly <strong>un</strong>der <strong>the</strong>control of <strong>the</strong>ir Governments or specifically approved by <strong>the</strong>m;b) Require that manufacture, trade, distribution and possession be <strong>un</strong>der a speciallicence or prior authorisation;c) Provide for close supervision of <strong>the</strong> activities and acts mentioned in paragraphs a) andb);d) Restrict <strong>the</strong> amo<strong>un</strong>t supplied <strong>to</strong> a duly authorised person <strong>to</strong> <strong>the</strong> quantity required forhis authorised purpose;e) Require that persons performing medical and scientific f<strong>un</strong>ctions keep recordsconcerning <strong>the</strong> acquisition of <strong>the</strong> substances and <strong>the</strong> details of <strong>the</strong>ir use, such records <strong>to</strong>be preserved for at least two years after <strong>the</strong> last use recorded <strong>the</strong>rein; and142
- Page 2 and 3:
ROADMAPS TO REFORMINGTHE UN DRUG CO
- Page 4 and 5:
ContentsPreface ...................
- Page 6 and 7:
PrefaceTHE IDEA FOR this Report cam
- Page 8:
PART I. POSSIBLE ROADMAPS
- Page 11 and 12:
hope for serious progress, but we c
- Page 13 and 14:
We do not underestimate the difficu
- Page 15 and 16:
also imposes requirements concernin
- Page 17 and 18:
domestic market, just as producers
- Page 19 and 20:
Protocol strengthened some provisio
- Page 21 and 22:
ut considerably less potency than s
- Page 23 and 24:
has announced its intention to reac
- Page 25 and 26:
objected to. Concerning the 1971 tr
- Page 27 and 28:
Table 2. Summary of reservations to
- Page 29 and 30:
Reservations about traditional use
- Page 31 and 32:
As Swaine notes, ‘the Vienna Conv
- Page 33 and 34:
unhappy about a country implementin
- Page 35 and 36:
Preemption by a new ‘single conve
- Page 37 and 38:
and their effort was rejected by a
- Page 39 and 40:
national or subnational level. Proh
- Page 42 and 43:
Chapter 5. Proposed treaty amendmen
- Page 44 and 45:
Article 1. DefinitionsExcept where
- Page 46 and 47:
Article 36 - penal provisionsIn Art
- Page 48 and 49:
Article 7. Special Provisions regar
- Page 50 and 51:
and to ensure adequate supplies of
- Page 52 and 53:
Article 1 − definition of ‘cons
- Page 54 and 55:
Article 19 - estimates of drug requ
- Page 56 and 57:
Article 21. Limitation of Manufactu
- Page 58 and 59:
contrary to a law or regulation ado
- Page 60 and 61:
1. in subparagraph (a):a) after ‘
- Page 62 and 63:
) for ‘in accordance with paragra
- Page 64 and 65:
include a number of general stateme
- Page 66 and 67:
the legality of drug possession. A
- Page 68 and 69:
Chapter 7. Conforming the 1961 Conv
- Page 70 and 71:
solely by Article 30, which require
- Page 72 and 73:
on trade activities referred to in
- Page 74 and 75:
(c) Require that licensed manufactu
- Page 76 and 77:
issued in the form of counterfoil b
- Page 78:
APPENDIXDETAILED COMMENTARY ON AMEN
- Page 81 and 82:
Articles 21-34 of the Convention im
- Page 83 and 84:
dispatch, transport, supply, purcha
- Page 85 and 86:
actions involving commercial quanti
- Page 87 and 88:
In the 1971 Convention the followin
- Page 89 and 90:
4.1.3 Option 2 - changes to Preambl
- Page 91 and 92:
separate estimates and statistical
- Page 93 and 94:
After ‘scientific research’, in
- Page 95 and 96:
would also include transforming a d
- Page 97 and 98:
(c) subject to the provisions of th
- Page 99 and 100: endangered’ by a Party’s failur
- Page 101 and 102: Article 9. Composition and Function
- Page 103 and 104: 2. The Board shall, in respect of c
- Page 105 and 106: for the right of the INCB to establ
- Page 107 and 108: ) Subject to the deductions referre
- Page 109 and 110: excess quantity must be deducted fr
- Page 111 and 112: prohibition in Article 31(1)(b) aga
- Page 113 and 114: 4.8 Article 20 - statistical return
- Page 115 and 116: separate returns would be required
- Page 117 and 118: 4.9.1 General comments on Article 2
- Page 119 and 120: distributors), and any quantity tak
- Page 121 and 122: a) The quantity consumed, within th
- Page 123 and 124: Article 21 bis. Limitation of Produ
- Page 125 and 126: to engage in cultivation; and culti
- Page 127 and 128: the purposes of Option 2. However,
- Page 129 and 130: in Article 29 to manufacture of mor
- Page 131 and 132: ) (i) Require medical prescriptions
- Page 133 and 134: 4.15 Article 31(1) - international
- Page 135 and 136: commercial use. Export to a state o
- Page 137 and 138: would automatically mean that posse
- Page 139 and 140: preparatory acts, conspiracy and at
- Page 141 and 142: offering for sale, distribution, 17
- Page 143 and 144: Article 36. Penal Provisions1. a) S
- Page 145 and 146: Article 36. Penal Provisions1. a) S
- Page 147 and 148: Conference would have intended to a
- Page 149: drugs (in more than small quantitie
- Page 153 and 154: apply to Schedule 1 substances. In
- Page 155 and 156: substances (of more than a small qu
- Page 157 and 158: 1. The Parties shall require that t
- Page 159 and 160: individuals may lawfully obtain, us
- Page 161 and 162: 4. The Parties shall furnish to the
- Page 163 and 164: 2. In subparagraph (b):a) after ‘
- Page 165 and 166: obligations on Parties in respect o
- Page 167 and 168: penalise preparatory acts in connec
- Page 169 and 170: accordance with subparagraph (a) of
- Page 171 and 172: Article 3(1)(c)(iii) warrants speci
- Page 173 and 174: 6.1.2. Option 1 - changes to the 19
- Page 175 and 176: uncertainty. Accordingly, Article 3
- Page 177 and 178: Consequently, Parties would also no
- Page 179: …4. d) The Parties may provide, e